Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

UPDATED

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study of Nivolumab + INCB24360

Birmingham Alabama 35243

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Birmingham Alabama 35243

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

View More ▼

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mobile Alabama 36608

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Arizona

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

UPDATED

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Chandler Arizona 85224

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Phoenix Arizona 85016

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

View More ▼

Phoenix Arizona

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Phoenix Arizona 85032

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Scottsdale Arizona 85258

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona 85259

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using LY3009120 capsule for patients With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Scottsdale Arizona

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Melanoma

Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Tucson Arizona 85719

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Arkansas

UPDATED

Rogers Arkansas 72758

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Fayetteville Arkansas 72703

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fayetteville Arkansas 72703

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Hot Springs Arkansas 71913

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

View More ▼

Little Rock Arkansas 72205

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

California

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

UPDATED

Irvine California 92612

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

UPDATED

La Jolla California 92093

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

UPDATED

La Jolla California 92093

A Phase 3 clinical study for patients with Melanoma

UPDATED

Los Angeles California 90033

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

View More ▼

UPDATED

Los Angeles California 90025

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

UPDATED

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

UPDATED

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90095

A Phase 1/Phase 2 clinical study for patients with Melanoma

UPDATED

Los Angeles California 90025

A Phase 1/Phase 2 clinical study for patients with Melanoma

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

UPDATED

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

UPDATED

Los Angeles California

Patients are needed to participate in a clinical research study of Nivolumab + INCB24360

UPDATED

Los Angeles California 90027

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

UPDATED

Newport Beach California 92625

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

UPDATED

Orange California 92868

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

UPDATED

Roseville California 95661

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

UPDATED

San Francisco California 94143

A Phase 3 clinical study for patients with Melanoma

UPDATED

San Francisco California 94115

A Phase 3 clinical study for patients with Melanoma

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

UPDATED

Santa Clara California 95051

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma